Fenretinide has potential for GA
Oral drug fenretinide has potential for the treatment of geographic atrophy (GA), but further studies are required.
Mushroom configuration can perform corneal cuts
Femtosecond laser (FSL)-assisted mushroom configuration deep anterior lamellar keratoplasty (DALK) is reliable and reproducible, stated a recent noncomparative case series.
Risk factors for esotropia reoperation revealed
Underaction of the lateral rectus muscle could be a risk factor for reoperation of congenital esostropia, claims an investigation in the Journal of Pediatric Ophthalmology and Strabismus.
Eye viscosity increases with age
According to a paper published in Clinical and Experimental Ophthalmology, loss of energy due to elastic hysteresis positively correlates with age, leading to the belief that eye viscosity increases with age.
Monitoring glaucoma progression with SLP
SLP has excellent reproducibility and may be useful in monitoring glaucoma progression.
Caution needed for full correction in low astigmatism
Caution should be used when considering full astigmatic correction for manifest cylinder of 0.5 D or less in myopic patients, according to the latest investigation in the Journal of Cataract and Refractive Surgery.
ICRS depth less than expected using OCT
Depth of intrastromal corneal ring segments (ICRS) is less than expected in myopic patients when measured by OCT, claims a recent paper.
EyeTechCare secures third round of funding for EyeOP1
EyeTechCare has secured ?10 million in a third round of funding for two international clinical trials for the EyeOP1 glaucoma treatment.
Retinal implant provides artificial sight for the blind
Retinal prosthesis systems (RPS) enable patients with retinal dystrophies to identify letters and words, confirms a new study.
Laser confocal imaging useful for AMD
Scanning laser ophthalmoscopy with a lateral confocal aperture could highlight subclinical drusen and aid in the progression of monitoring in AMD patients, claims the latest paper in the British Journal of Ophthalmology.
Vision UK 2013 speakers announced
The Vision UK 2013 conference, on the 11 June, has confirmed several key speakers, announced the UK Vision Strategy.
Aciex and Portola enter into research agreement
Aciex Therapeutics and Portola Pharmaceuticals have entered into a collaborative agreement to develop drugs for the treatment of topical ophthalmic diseases, according to the latest press release.
POAG detection successful with tract-based spatial imaging
Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.
OSST should be closely monitored for rejection
Ocular surface stem cell transplantation (OSST) patients should be closely monitored for rejection and compliance with immunosuppression.
ECD not linked to CCT in keratoconus
Corneal endothelial cell density (ECD) changes are independent from central corneal thickness (CCT) in keratoconus patients, states a recent paper.
PED volume and area changes could indicate retreatment
Volume and area changes in retinal pigment epithelial detachments (PEDs) could indicate the need for retreatment in eyes undergoing SD-OCT guided anti-VEGF therapy.
High patient satisfaction for ocular hypotensives
Glaucoma and ocular hypertension (OHT) patients are highly satisfied with ocular hypertensives, claims a recent investigation.
A-P method may calculate IOL power
The anterior-posterior (A-P) method is effective for calculating IOL power when preoperative LASIK data is unavailable.
Aflibercept injections improves VA in CRVO patients
Monthly intravitreal aflibercept significantly improves visual acuity (VA) in patients with macular oedema secondary to central retinal vein occlusion (CRVO), according to the latest phase of the COPERNICUS study.
Vision UK 2013 call for papers
The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013 conference.
Clobetasone butyrate safe and effective for SS
Low doses of clobetasone butyrate drops are safe and effective for Sj?gren syndrome (SS), claims an investigation.
Coats' disease treated with bevacizumab
Bevacizumab could play a role in treating Coats' disease, claims a recent study.
Loteprednol etabonate controls inflammation and IOP
Loteprednol etabonate controls inflammation and reduces IOP fluctuation after cataract surgery, according to a recent study.
Beclomethasone nasal spray doesn't increase IOP
Beclomethasone nasal spray doesn't increase IOP in patients with ocular hypertension and primary open-angle glaucoma, reveals a study in the Journal of Glaucoma.
ICG-enhanced TTT effectively treats retinoblastoma
Indocyanine green (ICG) enhanced transpupillary thermotherapy (TTT) in combination with ophthalmic artery chemosurgery can effectively treat retinoblastoma refractory without ocular side effects, claims a study.
Strategic alliance for clinical research announced
Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide clinical research and product development services for the ophthalmic industry.
Ivantis completion of financing novel glaucoma procedure
Ivantis announced the completion of financing $27 million for a novel glaucoma procedure at the Glaucoma Research Foundation's latest meeting.
Geuder supports CEPRECE eye clinic
Geuder has announced its support for ophthalmic clinic CEPRECE, based in Cusco, Peru.
Anti-VEGF therapy not as harmful as previously thought
Anti-VEGF therapy doesn?t not significantly affect visual acuity and metamorphopsia in patients treated for retinal pigment epithelium tears in eyes, according to a paper featured in Retina.
Optical biometry is the most precise
Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.
